Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
01 1PCAS
01 1Tartaric acid alimemazine
01 1France
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Registration Number : 218MF10151
Registrant's Address : 23, rue Bossuet Z. I. de la Vigne aux Loups F-91160 LONGJUMEAU France
Initial Date of Registration : 2006-01-31
Latest Date of Registration : 2010-02-23
A Alimemazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alimemazine, including repackagers and relabelers. The FDA regulates Alimemazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alimemazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Alimemazine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Alimemazine supplier is an individual or a company that provides Alimemazine active pharmaceutical ingredient (API) or Alimemazine finished formulations upon request. The Alimemazine suppliers may include Alimemazine API manufacturers, exporters, distributors and traders.
click here to find a list of Alimemazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Alimemazine Drug Master File in Japan (Alimemazine JDMF) empowers Alimemazine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Alimemazine JDMF during the approval evaluation for pharmaceutical products. At the time of Alimemazine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Alimemazine suppliers with JDMF on PharmaCompass.
LOOKING FOR A SUPPLIER?
